1. Home
  2. NAMS vs AVA Comparison

NAMS vs AVA Comparison

Compare NAMS & AVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAMS
  • AVA
  • Stock Information
  • Founded
  • NAMS 2019
  • AVA 1889
  • Country
  • NAMS Netherlands
  • AVA United States
  • Employees
  • NAMS N/A
  • AVA N/A
  • Industry
  • NAMS Biotechnology: Pharmaceutical Preparations
  • AVA Power Generation
  • Sector
  • NAMS Health Care
  • AVA Utilities
  • Exchange
  • NAMS Nasdaq
  • AVA Nasdaq
  • Market Cap
  • NAMS 2.9B
  • AVA 3.1B
  • IPO Year
  • NAMS N/A
  • AVA N/A
  • Fundamental
  • Price
  • NAMS $25.07
  • AVA $37.30
  • Analyst Decision
  • NAMS Strong Buy
  • AVA Sell
  • Analyst Count
  • NAMS 9
  • AVA 2
  • Target Price
  • NAMS $41.00
  • AVA $38.00
  • AVG Volume (30 Days)
  • NAMS 843.1K
  • AVA 788.2K
  • Earning Date
  • NAMS 08-06-2025
  • AVA 08-06-2025
  • Dividend Yield
  • NAMS N/A
  • AVA 5.25%
  • EPS Growth
  • NAMS N/A
  • AVA N/A
  • EPS
  • NAMS N/A
  • AVA 2.24
  • Revenue
  • NAMS $64,006,000.00
  • AVA $1,955,000,000.00
  • Revenue This Year
  • NAMS N/A
  • AVA $3.82
  • Revenue Next Year
  • NAMS $73.09
  • AVA $4.27
  • P/E Ratio
  • NAMS N/A
  • AVA $16.65
  • Revenue Growth
  • NAMS 762.15
  • AVA 2.44
  • 52 Week Low
  • NAMS $14.06
  • AVA $34.80
  • 52 Week High
  • NAMS $27.29
  • AVA $43.09
  • Technical
  • Relative Strength Index (RSI)
  • NAMS 61.96
  • AVA 46.72
  • Support Level
  • NAMS $24.73
  • AVA $35.88
  • Resistance Level
  • NAMS $25.80
  • AVA $37.92
  • Average True Range (ATR)
  • NAMS 1.33
  • AVA 0.55
  • MACD
  • NAMS 0.17
  • AVA 0.03
  • Stochastic Oscillator
  • NAMS 83.46
  • AVA 58.44

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

About AVA Avista Corporation

Avista Corp is an electric and natural gas utility company. The company has two business segments including Avista Utilities, which provides electric distribution and transmission, and natural gas distribution services in parts of eastern Washington and northern Idaho, and also provides natural gas distribution service in parts of northeastern and southwestern Oregon. Avista Utilities has electric generating facilities in Washington, Idaho, Oregon, and Montana. AEL&P is a regulated utility providing electric services in Juneau, Alaska that is a wholly-owned subsidiary and the primary operating subsidiary of AERC.

Share on Social Networks: